Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Malaria has been a major global health problem in recent times with increasing mortality. Current treatment methods include parasiticidal drugs and vaccinations. However, resistance among malarial parasites to the existing drugs has emerged as a significant area of concern in anti-malarial drug design. Researchers are now desperately looking for new targets to develop anti-malarials drug which is more target specific. Malarial parasites harbor a plastid-like organelle known as the ‘apicoplast’, which is thought to provide an exciting new outlook for the development of drugs to be used against the parasite. This review elaborates on the current state of development of novel compounds targeted againstemerging malaria parasites. Methods: The apicoplast, originates by an endosymbiotic process, contains a range of metabolic pathways and housekeeping processes that differ from the host body and thereby presents ideal strategies for anti-malarial drug therapy. Drugs are designed by targeting the unique mechanism of the apicoplasts genetic machinery. Several anabolic and catabolic processes, like fatty acid, isopenetyl diphosphate and heme synthess in this organelle, have also been targeted by drugs. Results: Apicoplasts offer exciting opportunities for the development of malarial treatment specific drugs have been found to act by disrupting this organelle’s function, which wouldimpede the survival of the parasite. Conclusion: Recent advanced drugs, their modes of action, and their advantages in the treatment of malaria by using apicoplasts as a target are discussed in this review which thought to be very useful in desigining anti-malarial drugs. Targetting the genetic machinery of apicoplast shows a great advantange regarding anti- malarial drug design. Critical knowledge of these new drugs would give a healthier understanding for deciphering the mechanism of action of anti-malarial drugs when targeting apicoplasts to overcome drug resistance.
Abstract
Objectives: Malaria has been a major global health problem in recent times with increasing mortality. Current treatment methods include parasiticidal drugs and vaccinations. However, resistance among malarial parasites to the existing drugs has emerged as a significant area of concern in anti-malarial drug design. Researchers are now desperately looking for new targets to develop anti-malarials drug which is more target specific. Malarial parasites harbor a plastid-like organelle known as the ‘apicoplast’, which is thought to provide an exciting new outlook for the development of drugs to be used against the parasite. This review elaborates on the current state of development of novel compounds targeted againstemerging malaria parasites. Methods: The apicoplast, originates by an endosymbiotic process, contains a range of metabolic pathways and housekeeping processes that differ from the host body and thereby presents ideal strategies for anti-malarial drug therapy. Drugs are designed by targeting the unique mechanism of the apicoplasts genetic machinery. Several anabolic and catabolic processes, like fatty acid, isopenetyl diphosphate and heme synthess in this organelle, have also been targeted by drugs. Results: Apicoplasts offer exciting opportunities for the development of malarial treatment specific drugs have been found to act by disrupting this organelle’s function, which wouldimpede the survival of the parasite. Conclusion: Recent advanced drugs, their modes of action, and their advantages in the treatment of malaria by using apicoplasts as a target are discussed in this review which thought to be very useful in desigining anti-malarial drugs. Targetting the genetic machinery of apicoplast shows a great advantange regarding anti- malarial drug design. Critical knowledge of these new drugs would give a healthier understanding for deciphering the mechanism of action of anti-malarial drugs when targeting apicoplasts to overcome drug resistance.
참고문헌 (69)
- "World Malaria Report 2015" (2015)[URL]
- Hayton K, "Drug resistance and genetic mapping in Plasmodium falciparum", Curr Genet, 54(5), pp.223~239 (2008)
- Gleeson MT, "The plastid in Apicomplexa : what use is it?", Int J Parasitol, 30(10), pp.1053~1070 (2000)
- Bouchut A, "Vesicles bearing Toxoplasma apicoplast membrane proteins persist following loss of the relict plastid or Golgibody disruption", PLoS One, 9(11), pp.e112096~ (2014)
- Kalanon M, "Malaria, Plasmodium falciparum and its apicoplast", Biochem Soc Trans, 38(3), pp.775~782 (2010)
- Ralph SA, "Tropical infectious diseases : metabolic maps and functions of the Plasmodium falciparum apicoplast", Nat Rev Microbiol, 2(3), pp.203~216 (2004)
- White NJ, "Antimalarial drug resistance", J Clin Invest, 113(8), pp.1084~1092 (2004)
- Cowman AF, "Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine", Proc Natl Acad Sci USA, 91(3), pp.1143~1147 (2004)
- Plowe CV, "Monitoring antimalarial drug resistance : making the most of the tools at hand", J Exp Biol, 206(21), pp.3745~3752 (2003)
- Arisue N, "Phylogeny and evolution of apicoplasts and apicomplexan parasites", Parasitol Int, 64(3), pp.254~259 (2015)
- Miotto O, "Genetic architecture of artemisinin-resistant Plasmodium falciparum", Nat Genet, 47(3), pp.226~234 (2015)
- Chandey M, "Quinine-resistant severe falciparum malaria in north India : documentation", Indian Journal of Medical Specialities, 4(1), pp.99~102 (2013)
- Awab GR, "Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan : an open randomized, non-inferiority, trial", Malar J, 9, pp.105~ (2010)
- Farooq U, "Drug resistance in malaria", J Vector Borne Dis, 41(3-4), pp.45~53 (2004)
- Eastman RT, "Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites", Antimicrob Agents Chemother, 55(8), pp.3908~3916 (2011)
- Barnes KI, "Sulfadoxine-pyrimethamine pharmacokinetics in malaria : pediatric dosing implications", Clin Pharmacol Ther, 80(6), pp.582~596 (2006)
- Dondorp AM, "Artemisinin resistance in Plasmodium falciparum malaria", N Engl J Med, 361(5), pp.455~467 (2009)
- Imwong M, "Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum", Antimicrob Agents Chemother, 54(7), pp.2886~2892 (2010)
- Heuchert A, "Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time : regional surveillance from 2006 to 2013", Malar J, 14, pp.208~ (2015)
- Liting L, "The evolution, metabolism and functions of the apicoplast", Philos Trans R Soc Lond B Biol Sci, 365(1541), pp.749~763 (2010)
- Macrae JI, "The apicoplast : a key target to cure malaria", Curr Pharm Des, 18(24), pp.3490~3504 (2012)
- Stuart A. Ralph, "The apicoplast as an antimalarial drug target", Drug Resistance Updates, 4(3), pp.145~151 (2001)
- Abrahamsen MS, "Complete genome sequence of the apicomplexan, Cryptosporidium parvum", Science, 304(5669), pp.441~445 (2004)
- Moore RB, "A photosynthetic alveolate closely related to apicomplexan parasites", Nature, 451(7181), pp.959~963 (2008)
- Dar MA, "Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes : unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit", Eukaryot Cell, 6(3), pp.398~412 (2007)
- Raghu Ram EV, "Nuclear gyrB encodes a functional subunit of the Plasmodium falciparum gyrase that is involved in apicoplast DNA replication", Mol Biochem Parasitol, 154(1), pp.30~39 (2007)
- Goodman CD, "The effects of anti-bacterials on the malaria parasite Plasmodium falciparum", Mol Biochem Parasitol, 152(2), pp.181~191 (2007)
- Singh D, "Multiple replication origins within the inverted repeat region of the Plasmodium falciparum apicoplast genome are differentially activated", Mol Biochem Parasitol, 139(1), pp.99~106 (2005)
- Onodera Y, "Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis", J Antimicrob Chemother, 47(4), pp.447~450 (2001)
- Dahl EL, "Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast", Antimicrob Agents Chemother, 51(10), pp.3485~3490 (2007)
- Goodman CD, "Ycf93 (Orf105), a small apicoplast-encoded membrane protein in the relict plastid of the malaria parasite Plasmodium falciparum that is conserved in Apicomplexa", PLoS One, 9(4), pp.e91178~ (2014)
- Gray MW, "Transcription in chloroplasts and mitochondria : a tale of two polymerases", Trends Microbiol, 6(1), pp.1~3 (1998)
- Li J, "Identification and characterization of a Plasmodium falciparum RNA polymerase gene with similarity to mitochondrial RNA polymerases", Mol Biochem Parasitol, 113(2), pp.261~269 (2001)
- McConkey GA, "Inhibition of Plasmodium falciparum protein synthesis. targeting the plastid-like organelle with thiostrepton", J Biol Chem, 272(4), pp.2046~2049 (1997)
- Dahl EL, "Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum", Antimicrob Agents Chemother, 50(9), pp.3124~3131 (2006)
- Pradel G, "Antibiotics in malaria therapy and their effect on the parasite apicoplast", Curr Mol Med, 10(3), pp.335~349 (2010)
- Chaubey S, "The apicoplast of Plasmodium falciparum is translationally active", Mol Microbiol, 56(1), pp.81~89 (2005)
- Haider A, "Targeting and function of proteins mediating translation initiation in organelles of Plasmodium falciparum", Mol Microbiol, 96(4), pp.796~814 (2015)
- Gupta A, "Recycling factors for ribosome disassembly in the apicoplast and mitochondrion of Plasmodium falciparum", Mol Microbiol, 88(5), pp.891~905 (2013)
- Budimulja AS, "The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors", Mol Biochem Parasitol, 84(1), pp.137~141 (1997)
- Lemgruber L, "Cryo-electron tomography reveals four-membrane architecture of the Plasmodium apicoplast", Malar J, 12, pp.25~ (2013)
- Botté CY, "Plasmodium falciparum apicoplast drugs: targets or off-targets", Chem Rev, 112(3), pp.1269~1283 (2012)
- Lindner J, "Trafficked proteins-druggable in Plasmodium falciparum", Int J Cell Biol, 2013, pp.e435981~ (2013)
- Sahu R, "In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine", Malar J, 13, pp.414~ (2014)
- Shears MJ, "Fatty acid metabolism in the Plasmodium apicoplast: Drugs, doubts and knockouts", Mol Biochem Parasitol, 199(1-2), pp.34~50 (2015)
- McLeod R, "Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I", Int J Parasitol, 31(2), pp.109~113 (2001)
- Waller RF, "Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum", Proc Natl Acad Sci USA, 95(21), pp.12352~12357 (1998)
- Haussig JM, "Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites", Mol Microbiol, 81(6), pp.1511~1525 (2011)
- Qidwai T, "Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum", Curr Drug Targets, 15(4), pp.374~409 (2014)
- Lichtenthaler HK, "Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway", FEBS Letters, 400(3), pp.271~274 (1997)
- Baumeister S, "Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways", PLoS One, 6(5), pp.e19334~ (2011)
- Jomaa H, "Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs", Science, 285(5433), pp.1573~1576 (1999)
- Gisselberg JE, "The suf iron-sulfur cluster synthesis pathway is required for apicoplast maintenance in malaria parasites", PLoS Pathog, 9(9), pp.e1003655~ (2013)
- Dellibovi-Ragheb TA, "Parasites FeS up: iron-sulfur cluster biogenesis in eukaryotic pathogens", PLoS Pathog, 9(4), pp.e1003227~ (2013)
- Seliverstov AV, "Comparative analysis of apicoplast-targeted protein extension lengths in apicomplexan parasites", Biomed Res Int, 2015, pp.e452958~ (2015)
- Lalève A, "The antimalarial drug primaquine targets Fe-S cluster proteins and yeast respiratory growth", Redox Biol, 7, pp.21~29 (2016)
- Wilson CM, "Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum", Mol Biochem Parasitol, 75(2), pp.271~276 (1996)
- Surolia N, "de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite", Biochem Biophys Res Commun, 187(2), pp.744~750 (1992)
- Bonday ZQ, "Import of host delta-aminolevulinate dehydratase into the malarial parasite : identification of a new drug target", Nat Med, 6(8), pp.898~903 (2000)
- Ke H, "The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages", J Biol Chem, 289(50), pp.34827~34837 (2014)
- Nagaraj VA, "Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infection", PLoS Pathog, 9(8), pp.e1003522~ (2013)
- Yeh E, "Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum", PLoS Biol, 9(8), pp.e1001138~ (2011)
- Morris GM, "AutoDock4 and AutoDock- Tools4: automated docking with selective receptor flexibility", J Comput Chem, 30(16), pp.2785~2791 (2009)
- Gupta A, "Reduced ribosomes of the apicoplast and mitochondrion of Plasmodium spp. and predicted interactions with antibiotics", Open Biol, 4(5), pp.e140045~ (2014)
- Sawhney B, "Identification of Plasmodium falciparum apicoplast-targeted tRNA-guanine transglycosylase and its potential inhibitors using comparative genomics, molecular modelling, docking and simulation studies", J Biomol Struct Dyn, 33(11), pp.2404~2420 (2015)
- Cilingir G, "ApicoAP: the first computational model for identifying apicoplast-targeted proteins in multiple species of Apicomplexa", PLoS One, 7(5), pp.e36598~ (2012)
- Pham JS, "A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys", Biochem J, 458(3), pp.513~523 (2014)
- Jackson KE, "Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum", Int J Parasitol, 42(2), pp.177~186 (2012)
- McFadden GI, "Apicomplexan plastids as drugtargets", Trends Microbiol, 7(8), pp.328~333 (1999)
